A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver Disease

Stopped early · Phase 2

Conditions studied: Cholestasis

In brief

The purpose of the study is to investigate if intravenous fish oil, commercially available as Omegaven, safely and effectively reverses parenteral nutrition associated cholestasis in children.

Key facts

Study ID
NCT00969332
Run by
University of California, Los Angeles
People needed
62
Starts
2009-08-01
Expected to finish
2019-02-12
Last updated by the study team
2020-02-26

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.